Tiny Model Organs Detect Liver Toxicity of New Drugs
Robert Fontana, MD provided evidence of the efficacy of a new drug-induced liver injury screening platform using human liver organoids.
Robert Fontana, MD provided evidence of the efficacy of a new drug-induced liver injury screening platform using human liver organoids.
Sameer Saini, MD, MS, and teams study reveals that presenting older adults with personalized information about the benefits and harms of colon cancer screening decreases screening excess.
Jason Knight, MD, PhD, and team find that targeting NETs could reduce the risk of heart attack and stroke for diabetic patients.
Beth Wallace, MD, and team discuss the potential side effects of taking oral steroids for short term use as well as long term use.
Mary Riwes, MD, and team’s research shows this could potentially prevent Graft versus Host Disease from occurring.
Patricia Bloom, MD, and Elliot Tapper, MD discuss the current understanding of efficacy, mechanism, and practical considerations of Lactulose in cirrhosis.
Jason Knight, MD, and team previously proved ginger root to halt autoimmune disease progression in mice and are now trialing the same concept in humans.
Ajjai Alva, MBBS, and team hope the results from a recent study on a breast and prostate cancer drug for patients with all types of advanced cancers can eventually lead to a decline in cancer-related deaths, especially for those with specific gene mutations.
Devraj Sukul, MD, MSc, and team discover the vast majority of people who have a minimally invasive heart valve replacement procedure do not participate in the recommended cardiac rehabilitation.
Neehar Parikh, MD, MS,examines various facets of care when treating liver cancer patients.
Jeffrey Kullgren, MD, MPH, MS, and team find that most people over 50 disagree with using life expectancy in guidelines for cancer screening tests.
Preeti Malani, MD, MS, and team summarize the therapeutic landscape in the US, discusses who is most likely to benefit from treatment, and highlight what is needed to improve COVID-19 treatment in the future.
Elizabeth Speliotes, MD, PhD, MPH, and teams found a better way to predict the individuals at highest risk for developing the disease, as well as provide direction for new therapeutics.
Jessica Golbus, MD and team find that tailored text messages to encourage high-risk people to move more may improve some short-term outcomes but doesn’t always improve physical activity levels for everyone.
Vincent Young, MD, PhD, and team find C. diff may not result from transmission, but from within the infected patient themselves.
Debbie Chen, MD proposes various potential interventions for hospitals and healthcare systems to implement to mitigate communication barriers.
Hallie Prescott, MD, CDC contributor, elaborates on a new program to help hospitalists combat sepsis.
Paul Swiecicki, MD has found quicker detection of HPV-positive head and neck cancer recurrence could lie in new monitoring guidelines and a more sensitive blood test.
Geoffrey Barnes, MD and team discover, despite new innovations, the death rate for pulmonary embolism remains high and unchanged in recent years – more often killing men, Black patients and those from rural areas.